ePRO/eCOA Featured Articles

  1. Preparing For The Next Pandemic: Lessons Learned 7/23/2024

    COVID-19 impacted how clinical trials are conducted and emphasized the need to stay ahead of emerging viruses and diseases. Explore insights on which measures and approaches will most likely continue to be implemented in the future.

  2. What Drives eConsent Adoption? Reasons May Be Different Than You Think 6/13/2024

    Increasing efficiency and reducing cost are significant drivers for adopting eConsent platforms. But are they really the factors holding back widespread adoption? Gatewood Global Principal Jeanie Magdalena Gatewood reveals other drivers in her independent research.

  3. Dear Data Analysts, AI Is Not Replacing You 4/2/2024

    Deep beneath the ongoing narrative of AI’s potential use cases in clinical trials is the same fear that persists in other industries facing a technology revolution. Will jobs be lost and replaced by machines? So, I thought I’d ask an expert — a machine.

  4. 3 Tips For Selecting Your eTMF Platform 3/7/2024

    Each eTMF platform presents its own set of advantages and drawbacks. Be sure to incorporate these three tips when considering a new eTMF vendor and its services.

  5. Increasing The Usefulness Of PROs In Oncology Research 2/20/2024

    Dr. Anthony Everhart (Clinical VP, Signant Health) and Tim Meyer (Professor, University College London) discuss opportunities for increasing the usefulness of PROMs.

  6. Can We Break The Digital Barrier In Clinical Trials? 1/22/2024

    In a recent episode of Clinical Leader Live, a panel of experts explore the barriers and benefits of leveraging technology in clinical trials.

  7. Enhancing Clinical Trial Efficiency & Compliance With eQMS 1/10/2024

    In recent years, electronic quality management systems (eQMS) have emerged as powerful tools to streamline and enhance the quality control processes in clinical trials. This article explores the key components, benefits, challenges, and future of eQMS in the context of clinical trials.

  8. How Can Electronic Data Capture Better Serve Decentralized Clinical Trials? 11/15/2023

    Newer, nimbler technology providers face a steep climb if they want to convince sponsors to sunset traditional EDC in favor of direct data capture only, or a unified decentralized trial platform that everything plugs into. Will EDC evolve to fix its existing problems, or will a different type of decentralized trial platform (or single platform model) replace pick-and-pull, add-and-subtract modules of clinical trial technology?

  9. Electronic Data Capture In Clinical Trials: What Needs To Improve? 11/14/2023

    Integrated technologies enhance clinical trial support, boosting the potential for quicker time-to-market. Key sponsors and CROs favoring operational efficiency prioritize "holistic study design," involving the integration of technologies (e.g., EDC, eCOA, and IRT) aligned with protocol, as opposed to constructing the study in individual tools.

  10. Regulatory Guidance For PRO Strategy In Oncology Trials 11/10/2023

    Kelly Dumais, Principal Scientific Advisor, and Jowita Marszewska, Scientific Advisor at Clario eCOA, delve into the specifics of how recent regulatory advancements are influencing PRO Strategy.